发明名称 |
Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives |
摘要 |
Inflammation or damage associated with myocardial events is treated or prevented by administration of an angiogenesis-inducing, anti-inflammatory peptide such as Thymosin β4, an isoform of Thymosin β4 or oxidized Thymosin β4. |
申请公布号 |
US9056087(B2) |
申请公布日期 |
2015.06.16 |
申请号 |
US200210488084 |
申请日期 |
2002.08.29 |
申请人 |
REGENERX BIOPHARMACEUTICALS, INC. |
发明人 |
Goldstein Allan L.;Finkelstein, Jr. Jack |
分类号 |
A61K38/22;C07K16/26;A61K39/00 |
主分类号 |
A61K38/22 |
代理机构 |
Rothwell, Figg, Ernst & Manbeck, P.C. |
代理人 |
Rothwell, Figg, Ernst & Manbeck, P.C. |
主权项 |
1. A method of enhancing myocardial tissue cell differentiation in a subject in need thereof, wherein cardiac endothelial cells are transformed to mesenchymal cells, comprising administering to said subject a composition comprising an effective amount of thymosin beta 4 (Tβ4) and a pharmaceutically acceptable carrier, wherein said Tβ4 is administered in a dosage of about 0.1 to 50 micrograms and at a concentration of 0.001-10% by weight. |
地址 |
Rockville MD US |